Dr. Mullins confirms that value in healthcare is incredibly important to both patients and insurance companies. The development of many new treatment options in the field of oncology makes it a prime place to look for value. Value can be determined by comparing evidence of cost and evidence of improved health outcomes.
Dr. Stainthorpe explains that the single payer perspective allows for negotiated terms and equality of access; however, they do not necessarily drive down costs the way multiple payers can.
Dr. Kolodziej explans how value based cancer care will greatly benefit the patient and physician
In this segment Dr. Kolodziej talks about the possibility of downside risk with payer/provider collaborations.
In this video Dr. Kolodziej discusses the major changes in payer/provider dialog and alternate payment moldes.
Listen to Dr. Kolodziej explain the oncology piolts he has been working on with Aenta.
During this segment Dr. Kolodziej discusses how there is a consistency with the vision people have.
Matthew Palmgren discusses impact on positive collaboration between the payer and physician
Jennifer Mailn discusses the benefits of improving quality of care through payer-provider collaborations
Jennifer Malin presents some of the lessons learned through payer-provider collaborations
Page 1 of 2
Results 1 - 10 of 14
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME